NCT07020221 2026-03-09A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsVerastem, Inc.Phase 1/2 Recruiting295 enrolled
NCT01397305 2020-09-09An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal CancerIsofol Medical ABPhase 1/2 Completed24 enrolled
NCT00190801 2007-01-26Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric CarcinomaEli Lilly and CompanyPhase 2 Completed50 enrolled